The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Kim et al., N Engl J Med 351(27):2875-2878 December 30, 2004.

Correction
PreviousPrevious
Volume 352:1163 March 17, 2005 Number 11
NextNext

Rofecoxib, Merck, and the FDA

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Kim, P. S.
Rofecoxib, Merck, and the FDA . In the letter by Topol, in Table 1 on page 2878, the 95 percent confidence interval for the number of total deaths and cardiovascular events in study group 090 should have been "1.2–46.3," rather than "1.2–146.3," as printed.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.